1. Home
  2. GPUS vs ONVO Comparison

GPUS vs ONVO Comparison

Compare GPUS & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • ONVO
  • Stock Information
  • Founded
  • GPUS 1969
  • ONVO 2007
  • Country
  • GPUS United States
  • ONVO United States
  • Employees
  • GPUS N/A
  • ONVO N/A
  • Industry
  • GPUS
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GPUS
  • ONVO Health Care
  • Exchange
  • GPUS NYSE
  • ONVO Nasdaq
  • Market Cap
  • GPUS 7.6M
  • ONVO 6.5M
  • IPO Year
  • GPUS 1996
  • ONVO N/A
  • Fundamental
  • Price
  • GPUS $4.70
  • ONVO $0.39
  • Analyst Decision
  • GPUS
  • ONVO
  • Analyst Count
  • GPUS 0
  • ONVO 0
  • Target Price
  • GPUS N/A
  • ONVO N/A
  • AVG Volume (30 Days)
  • GPUS 89.9K
  • ONVO 243.5K
  • Earning Date
  • GPUS 11-19-2024
  • ONVO 02-06-2025
  • Dividend Yield
  • GPUS N/A
  • ONVO N/A
  • EPS Growth
  • GPUS N/A
  • ONVO N/A
  • EPS
  • GPUS N/A
  • ONVO N/A
  • Revenue
  • GPUS $139,425,000.00
  • ONVO $103,000.00
  • Revenue This Year
  • GPUS N/A
  • ONVO $59.08
  • Revenue Next Year
  • GPUS N/A
  • ONVO $18.24
  • P/E Ratio
  • GPUS N/A
  • ONVO N/A
  • Revenue Growth
  • GPUS 3.50
  • ONVO N/A
  • 52 Week Low
  • GPUS $3.09
  • ONVO $0.32
  • 52 Week High
  • GPUS $44.43
  • ONVO $1.74
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • ONVO 47.81
  • Support Level
  • GPUS N/A
  • ONVO $0.34
  • Resistance Level
  • GPUS N/A
  • ONVO $0.51
  • Average True Range (ATR)
  • GPUS 0.00
  • ONVO 0.06
  • MACD
  • GPUS 0.00
  • ONVO -0.00
  • Stochastic Oscillator
  • GPUS 0.00
  • ONVO 30.00

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Share on Social Networks: